CollPlant Biotechnologies Ltd (CLGN) stock

CLGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as OPHI

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 9/30

$3.96+0.06 (+1.54%)

Close on Nov 11, 2026Market cap –P/E –Yield –

CollPlant Biotechnologies EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

CollPlant Biotechnologies's EV/EBITDA was 109.7× on Feb 28, 2023.

Period	Period end	Value	Change (pts)
2023	Feb 28, 2023	109.7×	+45.7
2022	Dec 30, 2022	64.0×	–

Parsed from the XBRL in CollPlant Biotechnologies's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Sep 4, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing